APOMORPHINE MYLAN 5 mg/ml, solution injectable
solution injectable
sous-cutanée
Autorisation active
Procédure nationale
Commercialisée
2/26/2019
MYLAN SAS
Business Listing - September 04, 2021
This is a premium business listing. Stand out from the competition!